根据名称进行药物检索

Zyrtec Syrup与肾/肝病

Zyrtec Syrup与肾/肝病安全配伍检测的结果。

检测结果:

Zyrtec Syrup <> 肾/肝病

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

西替利是消除主要通过的肾脏而且还要经过新陈代谢的肝脏一定程度上。患有肾和肝的疾病可能是在更大的风险不利影响，从西替利由于减少药物清关。制造商建议的一个初步剂量的5毫克每天一次的患者在6岁下降肾功能(肌酐清除率<=30毫升/分钟，其中包括那些在血液透析)和/或受损的肝功能。西替利应当优选中没有被使用儿童，低于6岁的肾和/或肝损伤，因为难以在可靠地施用剂量的小于2.5毫克(1/2茶匙)和缺乏药物动力学以及安全数据在这个人口。

来源

Simons FE, Watson WT, Minuk GY, Simons KJ "Cetirizine pharmacokinetics and pharmacodynamics in primary biliary cirrhosis." J Clin Pharmacol 33 (1993): 949-54
"Product Information. Zyrtec (cetirizine)." Pfizer US Pharmaceuticals, New York, NY.
Horsmans Y, Desager JP, Hulhoven R, Harvengt C "Single-dose pharmacokinetics of cetirizine in patients with chronic liver disease." J Clin Pharmacol 33 (1993): 929-32
Awni WM, Yeh J, Halstenson CE, Opsahl JA, Chung M, Matzke GR "Effect of haemodialysis on the pharmacokinetics of cetirizine." Eur J Clin Pharmacol 38 (1990): 67-9
Rihoux JP, Mariz S "Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy." Clin Rev Allergy 11 (1993): 65-88
Matzke GR, Yeh J, Awni WM, Halstenson CE, Chung M "Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency." Ann Allergy 59 (1987): 25-30
Barnes CL, McKenzie CA, Webster KD, Poinsett-Holmes K "Cetirizine: a new, nonsedating antihistamine." Ann Pharmacother 27 (1993): 464-70
Campoli-Richards DM, Buckley MM, Fitton A "Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria." Drugs 40 (1990): 762-81

Zyrtec Syrup

非专利名称: cetirizine

品牌: Zyrtec, All Day Allergy, All Day Allergy Children's, Indoor/Outdoor Allergy Relief, Zyrtec, GoodSense All Day Allergy

同义词: Cetirizine, Cetirizine (Systemic)

Zyrtec Syrup是什么？